These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20398099)

  • 1. Insulin signaling: a possible pathogenesis of cardiac hypertrophy.
    Yu W; Chen C; Fu Y; Wang X; Wang W
    Cardiovasc Ther; 2010 Apr; 28(2):101-5. PubMed ID: 20398099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
    Proud CG
    Cardiovasc Res; 2004 Aug; 63(3):403-13. PubMed ID: 15276465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy.
    Gul R; Park JH; Kim SY; Jang KY; Chae JK; Ko JK; Kim UH
    Cardiovasc Res; 2009 Feb; 81(3):582-91. PubMed ID: 18719074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
    Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
    Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress: a possible pathogenesis of atrial fibrillation.
    Huang CX; Liu Y; Xia WF; Tang YH; Huang H
    Med Hypotheses; 2009 Apr; 72(4):466-7. PubMed ID: 19103473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
    Merten KE; Jiang Y; Feng W; Kang YJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats.
    Kuo WW; Chung LC; Liu CT; Wu SP; Kuo CH; Tsai FJ; Tsai CH; Lu MC; Huang CY; Lee SD
    Cell Biochem Funct; 2009 Oct; 27(7):479-87. PubMed ID: 19718675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.
    Shiojima I; Walsh K
    Genes Dev; 2006 Dec; 20(24):3347-65. PubMed ID: 17182864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy.
    McMullen JR; Izumo S
    Novartis Found Symp; 2006; 274():90-111; discussion 111-7, 152-5, 272-6. PubMed ID: 17019808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of estradiol on insulin signaling in the rat heart.
    Koricanac G; Milosavljevic T; Stojiljkovic M; Zakula Z; Tepavcevic S; Ribarac-Stepic N; Isenovic ER
    Cell Biochem Funct; 2009 Mar; 27(2):102-10. PubMed ID: 19226537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
    Heger J; Schiegnitz E; von Waldthausen D; Anwar MM; Piper HM; Euler G
    J Cell Physiol; 2010 Jul; 224(1):120-6. PubMed ID: 20232299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
    Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cardiac hypertrophy by intracellular signalling pathways.
    Heineke J; Molkentin JD
    Nat Rev Mol Cell Biol; 2006 Aug; 7(8):589-600. PubMed ID: 16936699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca(2+)-growth coupling in angiotensin II-induced hypertrophy in cultured rat cardiac cells.
    Kinugawa K; Takahashi T; Kohmoto O; Yao A; Ikenouchi H; Serizawa T
    Cardiovasc Res; 1995 Sep; 30(3):419-31. PubMed ID: 7585834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-beta 1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy].
    Sakata Y
    Hokkaido Igaku Zasshi; 1993 Jan; 68(1):18-28. PubMed ID: 8383086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy.
    Fanzani A; Colombo F; Giuliani R; Preti A; Marchesini S
    FEBS J; 2006 Aug; 273(16):3709-21. PubMed ID: 16869890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation.
    Carneiro-Ramos MS; Diniz GP; Nadu AP; Almeida J; Vieira RL; Santos RA; Barreto-Chaves ML
    Basic Res Cardiol; 2010 May; 105(3):325-35. PubMed ID: 20155476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic cardiomyopathy and insulin resistance: a critical role for akt?
    Semple D; Smith K; Bhandari S; Seymour AM
    J Am Soc Nephrol; 2011 Feb; 22(2):207-15. PubMed ID: 20634295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.